Segment & Geographic Data Quant-Grade Normalized (live API) API & CSV Delivery

Bio Rad Laboratories Inc's Business Segments

Bio Rad Laboratories Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.

Segment Data As of Q2 FY2025
Reportable Segments
2
Per the company's own filing, this quarter
Largest Segment
Clinical Diagnostics
59.7% of revenue
Total Revenue
$ 651
Consolidated, this quarter
Regions Reported
3
Geographic regions, this quarter
API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/BIO/segments
https://api.csimarket.com/api/v1/companies/BIO/geographic
https://api.csimarket.com/api/v1/companies/BIO/exposure
Programmatic access for models, analytics, and integration workflows.
Pull these exact ratios programmatically
Dataset & schema
https://api.csimarket.com/api/datasets/business_segments
https://api.csimarket.com/api/schema/business_segments
https://api.csimarket.com/api/meta/business_segments

Revenue Share by Reportable Segment - Q2 FY2025

60%largest
  • Clinical Diagnostics59.7%
  • Life Science40.4%

Revenue by Reportable Segment - Q2 FY2025

SegmentPeriodRevenue
(Millions)
% of TotalOperating Income
Clinical DiagnosticsQ2 FY2025$ 38959.7%-
Life ScienceQ2 FY2025$ 26340.4%-

Revenue Share by Region - Q2 FY2025

33%largest
  • Europe33.3%
  • Asia Pacific19.4%
  • Americas6.3%

Revenue by Geographic Region - Q2 FY2025

RegionPeriodRevenue
(Millions)
% of Total
EuropeQ2 FY2025$ 21733.3%
Asia PacificQ2 FY2025$ 12619.4%
AmericasQ2 FY2025$ 416.3%

Description of Bio Rad Laboratories Inc

Bio-Rad Laboratories Inc. is a renowned multinational corporation that plays a pivotal role in the development and manufacturing of products for life science research and clinical diagnostics. Headquartered in Hercules, California, the company boasts a widespread presence with operations in over 100 countries around the globe.

Founded in 1952 by David and Alice Schwartz, Bio-Rad originated as a small-scale producer of specialty chemicals tailored for the scientific research community. With a commitment to innovation and quality, the company rapidly gained a reputation for excellence, which catalyzed its expansion into the manufacturing of advanced products utilized across various scientific applications, including microbiology, genetics, proteomics, and other facets of life sciences.

Today, Bio-Rad has established itself as one of the foremost manufacturers in the laboratory product and diagnostic system sectors globally. The company operates through two main divisions: Life Science and Clinical Diagnostics.

Life Science Division
The Life Science division of Bio-Rad caters to a diverse clientele, which includes research universities, biotechnology firms, pharmaceutical companies, and clinical research organizations. Its extensive product portfolio encompasses a wide range of reagents, instruments, and software solutions designed for various applications such as genomic research, proteomics, cell biology, and genetic analysis. Some of the key offerings include:

- PCR Products: Bio-Rad provides a suite of solutions for polymerase chain reaction (PCR), essential for amplifying DNA.
- Electrophoresis Equipment: The company produces gel and capillary electrophoresis instruments and reagents widely used in the analysis and separation of nucleic acids and proteins.
- Western Blotting: Bio-Rad is a recognized leader in the development of reagents and instruments for Western blotting, a critical technique for detecting specific proteins in complex samples.
- Cell Culture Products: The company offers a range of solutions that support researchers in cell culture, including culture media, supplements, and cell culture plates.
- Gene Expression and Analysis Tools: Their tools facilitate the study of gene expression and regulation, aiding researchers in discovering critical insights into cellular functions.

Clinical Diagnostics Division
In the Clinical Diagnostics segment, Bio-Rad develops and manufactures a broad array of products vital for the diagnosis and management of diseases. This division is particularly well-known for its contributions in several critical areas:

- Blood Typing and Transfusion Testing: Bio-Rad is recognized as a leading provider of products for blood typing, ensuring safe transfusions and compatibility among donor and recipient blood types.
- Infectious Disease Testing: The company produces diagnostic kits and systems used for the monitoring and detection of infectious diseases, enhancing patient care and public health outcomes.
- Diabetes Monitoring: Bio-Rad offers solutions that assist healthcare providers in monitoring diabetes, enabling better management of the condition through accurate testing.
- Autoimmunity Diagnostics: The company has developed assays and testing solutions to diagnose autoimmune diseases, facilitating better understanding and treatment of such conditions.

Commitment to Sustainability and Corporate Responsibility
Bio-Rad is dedicated to promoting sustainability and corporate responsibility within its operations. The company focuses on creating products that not only enhance laboratory efficiency but also aim to minimize environmental impact through waste reduction and resource conservation. This commitment to sustainability includes initiatives such as the development of eco-friendly products and the implementation of practices that contribute to environmental protection.

In addition to its operational goals, Bio-Rad engages in philanthropic activities that reflect its commitment to giving back to the community. This includes supporting science education, funding research initiatives, and partnering with organizations aimed at fostering educational opportunities in science and technology.

Innovation and Excellence
Overall, Bio-Rad Laboratories Inc. has carved a significant niche in the life sciences and diagnostics industry through its innovative product offerings and unwavering commitment to quality and excellence. With a robust pipeline of new products and a focus on research and development, the company continues to lead advancements that enhance scientific exploration and improve health outcomes globally. Bio-Rad is not just a major player in the industry; it is also a key partner to researchers, clinicians, and laboratories striving to make meaningful contributions to science and health care.
Bio-Rad Laboratories Inc. is a leading global provider of a wide range of products, services, and solutions that are integral to the fields of life science research, clinical diagnostics, and biopharmaceutical development. The companys operations are structured into three main segments: Life Science Research, Clinical Diagnostics, and Process Separations. Below is a detailed overview of each segment, highlighting the associated products and services that reinforce Bio-Rads position in the market.

Segments

1. Life Science Research:
The Life Science Research segment equips researchers across a plethora of life science applications with innovative technologies and resources. This segment can be further elaborated into:

- Protein Research:
- Electrophoresis Systems: Advanced equipment for protein separation based on size and charge, facilitating research in protein characterization.
- Protein Purification Kits: User-friendly solutions for isolating proteins from biological samples.
- Assays: Tools for quantifying and characterizing proteins, enabling researchers to understand protein function and interactions.

- Genomics:
- qPCR Systems: Real-time PCR instruments allowing for the quantification of DNA and RNA, critical for genomics studies.
- RNA and DNA Purification: Kits and reagents for isolating high-quality nucleic acids from various samples for downstream applications.
- Genetic Sequencing Solutions: Platforms and reagents that support next-generation sequencing (NGS) for comprehensive genome analysis.
- Gene Editing Technologies: Tools that enable precise editing of genomic DNA, including CRISPR/Cas9 systems tailored for diverse applications.

- Cell Biology Research:
- Cell Culture Products: A range of media, supplements, and plasticware designed for optimal growth and maintenance of cell lines.
- Cell Analysis Tools: Instruments and reagents for flow cytometry and imaging to assess cell viability, proliferation, and function.
- Cellular Imaging Solutions: High-resolution imaging systems for detailed visualization of cellular structures and processes.

Clinical Diagnostics:
Bio-Rads Clinical Diagnostics segment delivers essential testing solutions for clinical laboratories, hospitals, and reference labs. It focuses on:

- Diagnostic Testing:
- Assays and Reagents: A broad catalog of products allowing for the detection and monitoring of various diseases, such as infectious agents, diabetes markers, and cancer markers.
- Automated Testing Systems: Integrated platforms that streamline laboratory workflows while ensuring reliable and accurate results.

- Quality Control:
- Control Materials: Standardized materials that laboratories use to validate and ensure accuracy in test results across various assays.
- Validation Tools: Solutions that assist labs in implementing strict quality assurance protocols to maintain clinical testing standards.

Process Separations:
This segment supports the biopharmaceutical industry by providing essential tools for purification processes. Key components include:

- Chromatography Resins and Columns:
- Affinity Chromatography Resins: Specialty resins designed for the targeted purification of proteins, including antibodies.
- Ion Exchange Resins: Products that facilitate the separation of biomolecules based on charge, crucial for protein purification.
- Size Exclusion Chromatography: Resins that allow for the separation of molecules based on size, optimal for protein characterization.

- Purification Systems:
- Integrated Purification Platforms: Systems engineered to purify biologics such as monoclonal antibodies, vaccines, and therapeutic proteins in a seamless manner.

Products

- Bio-Plex: An advanced multiplex assay system that enables simultaneous detection and quantification of multiple analytes from a single sample, significantly enhancing throughput and efficiency in laboratory research.

- Gel Doc EZ: A digital imaging system tailored for high-quality capture of DNA, RNA, and protein gels, simplifying analysis and documentation in molecular biology.

- PCR Products: Comprehensive offerings, including thermal cyclers, reagents, and consumables for polymerase chain reaction (PCR), ensuring performance reliability in various molecular assays.

- D-Lux Camera: A specialized low-light CCD camera designed for imaging in chemiluminescence and fluorescence applications, facilitating precise detection of biomolecules in various experimental setups.

Services

- Custom Antibody Services: Tailored development services allowing researchers to create antibodies specific to their research needs, supporting a broad range of experimental applications.

- Protein Expression Services: Full-service offerings encompassing expressing, purifying, and characterizing recombinant proteins, enabling researchers to concentrate on subsequent experiments.

- Quality Control Solutions: Services that help laboratories establish and maintain rigorous quality assurance processes, ensuring accuracy and reliability of test results crucial for patient care and research outcomes.

- Training and Support: Extensive training and support services for all product lines, ensuring that researchers maximize the effectiveness and utility of Bio-Rads tools in real-world applications.

Conclusion
Bio-Rad Laboratories Inc. presents a comprehensive and diversified portfolio of products and services that cater to the dynamic needs of scientists and clinicians worldwide. Its unwavering commitment to innovation and quality not only supports critical research and clinical diagnostics but also plays a significant role in advancing biotechnology and healthcare initiatives.